Published on July 08, 2019

Mercy Fitzgerald Now Offers Stereotactic Radiosurgery

Mercy Fitzgerald now offers stereotactic radiosurgery (SRS), a radiation therapy that is noninvasive and is used to treat primary and metastatic tumors of the brain. SRS can help patients preserve healthy brain tissue, allowing improved preservation of cognitive function by delivering targeted radiation in fewer high-dose treatments than traditional radiation therapy.

“As cancer therapies improve, patients with brain tumors are living longer,” said Shefali R. Gajjar, MD, radiation oncologist at Mercy Fitzgerald Campus. “The new technology will allow us to administer effective treatment with minimal side effects, which will have a significant impact on improving the quality of life for our patients."

The multidisciplinary team at Mercy Fitzgerald involved in stereotactic radiosurgery includes radiation oncologists, neurosurgeons, radiologists, and oncology nurse navigators working together to design the best treatment plan. The number of stereotactic radiosurgery treatments can vary from one to five sessions and treatments are performed in an outpatient setting. Mercy Fitzgerald Campus is an accredited cancer center by the American College of Surgeons Commission on Cancer.

For more information on Mercy Fitzgerald’s stereotactic radiosurgery, or to schedule an appointment, please call 1.877.GO MERCY or visit trinityhealthma.org.